4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-23-014773
CHIEF EXECUTIVE OFFICER sold 1,092 shares at $10.42 ($11,379)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
NOYES TIMOTHY P · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-01 | Sale : show line 1 in the form 10b5-1 | −1,092 | $10.42 | $11,379 | 0 | D |
| Open-market sales · 1,092 sh · avg $10.42 · $11,379 | ||||||
Loading xslF345X05/form4-11032023_051101.xml…